When It Comes to Preventive and Proactive Wellness, Accessibility Is Key
Holistic care requires proactive pursuit of health services, which more people might seek if financing options are available to manage costs.
Aledade Rakes in $260M for Primary Care Network
Aledade's $260 million financing round was led by Lightspeed Venture Partners, a new investor of the company. It also included participation from Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management and Research Company.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Amino Health Secures $80M for Navigation Platform
Amino Health's $80 million in financing was led by Transformation Capital and Oxford Finance. With the funding, the company hopes to reach and engage more members and grow its partnerships with employers and third party administrators.
Biotech Financing Roundup: Belharra, NextPoint, Pathalys & More
Cancer continues to be a hot area of investment, and it’s the therapeutic focus of several biotech companies that have closed recent rounds of financing. Meanwhile, the investment arm of a big pharmaceutical company has an infusion of new cash to deploy in therapeutic and digital investments.
DispatchHealth Looks To Expand In-home Care With More Than $330M in Financing
The funding round was led by Optum Ventures. Other investors include Adams Street Partners, Blue Shield of California and Humana. DispatchHealth will use the money to expand its capabilities in current markets, its CEO said.
Innovaccer gains unicorn status, plans to launch cloud platform
The health technology company's valuation skyrocketed to $1.3 billion following its latest funding round. It plans to use the new funds to launch Innovaccer Health Cloud, which will aggregate and normalize data from different systems and support the development of interoperable apps.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Biotech Vividion lands $135M in crossover cash, paving a path to the public markets
Vividion Therapeutics has technology that enables it to develop drugs for “undruggable” disease targets. The Series C financing is a crossover round, an indication a biotech is preparing for an IPO.
presented by
Life Sciences Law Firm Index: Top Deal Firms Update
One year ago, in collaboration with Lake Whillans and our sister site MedCity News, we launched the inaugural Life Sciences Law Firm Index to recognize law firms that are the most active and relevant for life science companies. Over the course of 2016, we have published updates to the Index, each focusing on a different practice area. Today, […]